DNB
58
2
JPM
67
3
PHM
59
-2
ROK
44
2
MMM
44
2
AES
32
-5
KLAC
63
2
AON
49
4
GS
59
7
SPG
58
2
VMC
41
2
VLO
33
4
ZTS
38
4
CFG
48
2
ITW
59
3
RCL
83
6
YUM
40
-2
NVDA
61
-2
STZ
48
-2
APD
65
5
DNB
58
2
JPM
67
3
PHM
59
-2
ROK
44
2
MMM
44
2
AES
32
-5
KLAC
63
2
AON
49
4
GS
59
7
SPG
58
2
VMC
41
2
VLO
33
4
ZTS
38
4
CFG
48
2
ITW
59
3
RCL
83
6
YUM
40
-2
NVDA
61
-2
STZ
48
-2
APD
65
5
Financhill
Back

Halozyme Therapeutics Vs. Neurocrine Biosciences Industry Stock Comparison

Sell
30

HALO
Halozyme Therapeutics

Last Price:
51.64
Seasonality Move:
20.13%
Sell
25

NBIX
Neurocrine Biosciences

Last Price:
112.09
Seasonality Move:
18.05%
Sell
30
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $50.65. The Score for HALO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Neurocrine Biosciences (NBIX) is a Sell

Is Neurocrine Biosciences a Buy, Sell or Hold?

  • The current Neurocrine Biosciences [NBIX] share price is $111.62. The Score for NBIX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NBIX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $50.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

NBIX Stock Price Chart

What is Neurocrine Biosciences's stock price today?

  • The Neurocrine Biosciences share price today is $111.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight selling pressure.

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.4 Sell
Relative Strength Index (14 RSI): 30.8 Sell
Chaikin Money Flow: -1825954 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.62 - 61.32) Sell
Bollinger Bands (100): (49 - 60.08) Sell

NBIX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.94 Sell
Relative Strength Index (14 RSI): 28.72 Sell
Chaikin Money Flow: -147687 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (113.68 - 121) Sell
Bollinger Bands (100): (122.95 - 147.33) Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.28 Sell
20-day SMA: 58.18 Sell
50-day SMA: 58.64 Sell
200-day SMA: 46.49 Buy
8-day EMA: 55.36 Sell
20-day EMA: 57.29 Sell
50-day EMA: 57.37 Sell
200-day EMA: 49.67 Buy

NBIX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 113.06 Sell
20-day SMA: 116.55 Sell
50-day SMA: 130.72 Sell
200-day SMA: 135.95 Sell
8-day EMA: 113.12 Sell
20-day EMA: 117.04 Sell
50-day EMA: 125.73 Sell
200-day EMA: 130.63 Sell

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $0.79 per share.

Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.33 per share, and an increase next year of $1.55 per share.

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurocrine Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):